2015 was a big year for brain tumor research and advocacy. Today, we’re featuring the most read blogs from 2015 that focus on breakthrough science and community stories that both raise the profile of our disease and honor those who have worked tirelessly in the fight against brain tumors; either as patients or clinicians.
This top ten list encapsulates what made 2015 so memorable and sets the stage for 2016’s advancements.
1. this is … a brain tumor documentary unfolding in real time
Jennifer Keenan Giliberto’s photography captures life’s moments in an emotionally resonant way that transports the viewers into the narrative of each photo. Her meticulous eye is able to find and record a scene in a way that loses none of its impact. She’s also a brain tumor survivor. She wanted to show the world the true experience of living through diagnosis and treatment, and teamed up with a young couple going through this experience.
2. 60 Minutes Joins the Fight Against Brain Tumors
The esteemed weekly news program “60 Minutes” on CBS aired an in-depth story on a potential new treatment for glioblastoma multiforme GBM. The segment followed brain cancer patients in a Duke University clinical trial of a therapy that uses a re-engineered polio virus to kill tumor cells.
3. What does metabolism have to do with tumors? Defeat GBM-funded study offers new clues
Tumors can use two common nutrients in the body to block the efforts of current targeted therapies designed to treat glioblastoma (GBM) patients, according to a new study funded in part through the Defeat GBM Research Collaborative. This finding could be used to help develop more effective treatment approaches for GBM patients moving forward.
4. National Brain Tumor Society Statement on FDA Approval of Optune for Treatment of Glioblastoma Patients
National Brain Tumor Society’s (NBTS) Chief Executive Officer David Arons issued the following statement on the U.S. Food and Drug Administration’s (FDA) approval of Novocure’s Optune, a medical device to treat newly diagnosed glioblastoma multiforme (GBM) patients in combination with the chemotherapy temozolomide (brand name: Temodar) following standard treatment of surgery and radiation therapy.
5. Can a Tetanus Shot Help Fight Brain Tumors?
That’s not clickbait, but an interesting study on brain cancer – funded in part by the National Brain Tumor Society – was published in the prominent scientific and medical journal, Nature. The encouraging results of the study even sent ripples through mainstream health media, including stories in top-tier outlets including the Wall Street Journal, NBC News, and CBS News.
6. In Memory of Dr. Andrew Parsa
The brain tumor community lost a huge ally when Dr. Andrew (Andy) Parsa passed on April 13, 2015. Dr. Parsa had been serving as Chairman of Neurological Surgery at Northwestern University’s Feinberg School of Medicine, having previously been a Professor and Vice Chairman of the Department of Neurological Surgery at the University of California at San Francisco.
7. Survey Results: Brain Tumor Treatment & Diagnosis
Remember back in the summer of 2014 when we asked you to fill out our Patient and Caregiver Survey? Well we sure do, as your participation in this survey has provided not only us, but also the FDA, researchers, clinician, and drug makers with very valuable information so that we can design clinical trials.
8. Immunotherapy: A Two-Part Q&A with Dr. John Sampson
“Immunotherapy” is one of the hot topics in cancer research right now. If you follow cancer and brain tumor research news, you have no doubt by now heard about this treatment approach recently. Learn more about how immunotherapy relates to brain tumor treatments in this two-part Q&A with Dr. John Sampson.
9. Our Bold Response to the Deadliest of Brain Cancers
Guest blogger, Dr. Anna Barker, introduces the GBM AGILE Clinical Trial, the most aggressive approach to defeating GBM.
10. Congress Delivers Brain Tumor Community Holiday Gift
This post was out for less than a week and it cracked the top ten because of the major news it broke. The Congressional Budget has been passed and more money will be available for brain tumor research in 2016. None of that would have been possible without the brain tumor community’s advocacy.
As we go into 2015, we encourage you give a gift so we can continue to fund advocacy and research initiatives that bring us closer to the cure. Never before have we been so close to newer treatments. Together we can do this.
Wishing you the best for 2016,
Digital Communications Manager, NBTS